7-溴-3,4-二氢-1,5-苯并二噁庚 | 147644-11-9

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 7-溴-3,4-二氢-1,5-苯并二噁庚
• 中文别名: 7-溴-3,4-二羟基-2H-1,5-苯并二氧；3,4-二氢-7-溴-2H-苯并[1,4]二氧庚烷
• 英文名称: 7-bromo-3,4-dihydro-2H-1,5-benzodioxepine
• 英文别名: 7-bromo-3,4-dihydro-2H-[1,5]benzodioxepin；7-bromo-3,4-dihydro-2H-benzo[b][1,4]dioxepine；7-bromo-3,4-dihydro-2H-1,5-benzodioxepin
• CAS: 147644-11-9
• 化学式: C₉H₉BrO₂
• mdl: MFCD00508291
• 分子量: 229.073
• InChiKey: AZCHNKNSOZJHSH-UHFFFAOYSA-N

物化性质

• 沸点：
  82 °C
• 密度：
  1.504±0.06 g/cm3(Predicted)
• 闪点：
  145-148°C/16mm
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.333
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 安全说明：
  S26
• 危险类别码：
  R36/37/38
• 海关编码：
  2932999099
• 储存条件：
  保存方法：密闭、阴凉、通风干燥处。

SDS

Name:	7-Bromo-3 4-dihydro-2H-1 5-benzodioxepine 97% Material Safety Data Sheet
Synonym:
CAS:	147644-11-9

Section 1 - Chemical Product MSDS Name:7-Bromo-3 4-dihydro-2H-1 5-benzodioxepine 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
147644-11-9	7-Bromo-3,4-dihydro-2H-1,5-benzodioxep	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 147644-11-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: odorless - slight odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 82 - 94 deg C @0.15mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H9BrO2
Molecular Weight: 229.07

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 147644-11-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
7-Bromo-3,4-dihydro-2H-1,5-benzodioxepine - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 147644-11-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 147644-11-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 147644-11-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  sodium methylate 、 7-溴-3,4-二氢-1,5-苯并二噁庚 在 甲醇 、 甲酸甲酯 、 copper(l) chloride 作用下， 反应 2.0h， 以97%的产率得到7-methoxy-3,4-dihydro-2H-benzo[b]1,4-dioxepine
  参考文献：
  名称：

  A ligand-free, powerful, and practical method for methoxylation of unactivated aryl bromides by use of the CuCl/HCOOMe/MeONa/MeOH system

  摘要：

  一种无配体的强有效的方法已被开发用于非活化芳基溴化物的单甲氧基化和多甲氧基化；该反应使用CuCl作为催化剂，HCOOMe作为助催化剂，甲醇的MeONa作为亲核试剂和溶剂。这种环保的工艺具有操作简单、底物成本低（非活化单至多溴苯）、完全转化以及可直接回收纯MeOH的特点。

  DOI：

  10.1007/s11164-014-1917-x
• 作为产物：
  描述：

  3,4-二氢-2H-1,5-苯并二氧环庚烷 在 溴 、 sodium acetate 、 sodium carbonate 作用下， 以 正己烷 、 水 、 溶剂黄146 为溶剂， 生成 7-溴-3,4-二氢-1,5-苯并二噁庚
  参考文献：
  名称：

  Anilide derivative, production and use thereof

  摘要：

  这项发明提供了以下式的化合物： 其中R1是一个可选择取代的5至6成员环；环A是一个可选择取代的6至7成员环；环B是一个可选择取代的苯环；n是1或2的整数；Z是化学键或二价基团；R2是(1)一个可选择取代的氨基团，其中氮原子可以形成季铵盐，(2)一个可选择取代的含氮杂环环基团，可能含有硫原子或氧原子作为环构成原子，其中氮原子可以形成季铵盐，(3)通过硫原子结合的基团或(4)下式的基团： 其中k为0或1，当k为0时，磷原子可以形成磷铵盐；R5和R6分别是可选择取代的碳氢基团、可选择取代的羟基或可选择取代的氨基团，R5和R6可以结合在一起与相邻的磷原子形成环状基团，或其盐，用于拮抗CCR5并用于预防和治疗HIV感染疾病。

  公开号：

  US06235771B1

文献信息

• Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-Like Proteins
  申请人：Kroth Heiko

  公开号：US20110280808A1

  公开（公告）日：2011-11-17

  The present invention relates to novel compounds that can be employed in the treatment of a group of disorders and abnormalities associated with amyloid protein, such as Alzheimer's disease, and of diseases or conditions associated with amyloid-like proteins. The compounds of the present invention can also be used in the treatment of ocular diseases associated with pathological abnormalities/changes in the tissues of the visual system. The present invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the preparation of medicaments for treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins. A method of treating or preventing diseases or conditions associated with amyloid and/or amyloid-like proteins is also disclosed.

  本发明涉及一种新型化合物，可用于治疗与淀粉样蛋白相关的一组疾病和异常，如阿尔茨海默病，以及与淀粉样蛋白类似蛋白相关的疾病或病况。本发明的化合物还可用于治疗与视觉系统组织中的病理异常/变化相关的眼部疾病。本发明还涉及包含这些化合物的药物组合物，以及利用这些化合物制备用于治疗或预防与淀粉样和/或淀粉样类似蛋白相关的疾病或病况的药物的用途。还公开了一种治疗或预防与淀粉样和/或淀粉样类似蛋白相关的疾病或病况的方法。
• Diphenylethylene compounds and uses thereof
  申请人：Muller W. George

  公开号：US20050107339A1

  公开（公告）日：2005-05-19

  The present invention relates to Diphenylethylene Compounds and compositions comprising a Diphenylethylene Compound. The present invention also relates to methods for preventing or treating various diseases and disorders by administering to a subject in need thereof one or more Diphenylethylene Compounds. In particular, the invention relates to methods for preventing or treating cancer or an inflammatory disorder by administering to a subject in need thereof one or more Diphenylethylene Compounds. The present invention further relates to articles of manufacture and kits comprising one or more Diphenylethylene Compounds.

  本发明涉及二苯乙烯化合物和包含二苯乙烯化合物的组合物。本发明还涉及通过向需要的受试者施用一种或多种二苯乙烯化合物来预防或治疗各种疾病和紊乱的方法。具体而言，该发明涉及通过向需要的受试者施用一种或多种二苯乙烯化合物来预防或治疗癌症或炎症性紊乱的方法。本发明还涉及包含一种或多种二苯乙烯化合物的制品和工具包。
• [EN] GLYCOSIDASE INHIBITORS<br/>[FR] INHIBITEURS DE GLYCOSIDASES
  申请人：ASCENEURON SA

  公开号：WO2016030443A1

  公开（公告）日：2016-03-03

  Compounds of formula (I) wherein A, R, W, Q, n and m have the meaning according to the claims can be employed, inter alia, for the treatment of tauopathies and Alzheimer's disease.

  式（I）中A、R、W、Q、n和m的含义如权利要求所述，可用于治疗tau病和阿尔茨海默病。
• OPIOID RECEPTOR MODULATORS AND USE THEREOF
  申请人：National Health Research Institutes

  公开号：US20170056377A1

  公开（公告）日：2017-03-02

  Disclosed is an in vitro screening method for identifying an antagonist-to-agonist allosteric modifier of a mu-opioid receptor and an in vivo method for confirming that a test compound is such a modifier of a mu-opioid receptor. Also disclosed is a method for treating an opioid receptor-associated condition using a compound of Formula (I) and a pharmaceutical composition containing the same.

  揭示了一种体外筛选方法，用于识别μ-阿片受体的拮抗剂-激动剂异位调节剂，并揭示了一种体内方法，用于确认测试化合物是否为μ-阿片受体的这种调节剂。还揭示了一种使用式（I）化合物和含有该化合物的药物组合物治疗阿片受体相关疾病的方法。
• Chiral C2-symmetric biphenyls, their preparation and also metal complexes in which these ligands are present and their use as catalysts in chirogenic syntheses
  申请人：Peschko Christian

  公开号：US20050250951A1

  公开（公告）日：2005-11-10

  A new class of C 2 -symmetric biaryldiphosphines comprising a fused ring system (dioxacycle) which has at least seven ring atoms and can be varied synthetically. The biaryldiphosphines can be used as ligands for preparing metal complexes useful as catalysts in organic synthesis, and the dioxacycles can be varied to optimize reaction with specific substrates.

  一种新型的C2对称的双芳基二膦化合物，包括至少七个环原子的融合环系统（二氧环），可以在合成过程中进行变化。这些双芳基二膦化合物可以用作配体，用于制备金属配合物，这些金属配合物在有机合成中作为催化剂，而二氧环可以进行变化以优化与特定底物的反应。